
Dexcom Ventures
Dexcom Ventures is a health-innovation venture capital platform.
- 5
- Operating
- 2021
Library
dexcomventures.comCrawled Sep 24, 2026
Homepage
1 page- Homepage/
Accelerating innovation in biosensing and data-driven healthcare
Coverage
5 items- myBiometry: Asthma And COPD Diagnostic Company Raises $5 Million (Seed)pulse2.com/mybiometry-asthma-and-copd-diagnostic-company-raises-5-million-seed/
myBiometry secures $5 million in seed funding to advance its asthma and COPD diagnostic and remote monitoring solutions. The oversubscribed round is led by Dexcom Ventures, with additional support from CareSource Indiana and Elevate Ventures. The company focuses on improving respiratory disease management through technology-driven diagnostics.
Nov 2024Pulse 2.0News article
- Signos raises $20M for AI-powered CGM techdrugdeliverybusiness.com/signos-raises-20m-ai-cgm-tech/
Signos secures $20 million in Series B funding to advance its AI-driven continuous glucose monitoring (CGM) technology. The company develops wearable devices that track glucose levels in real time, leveraging machine learning for predictive insights. This funding supports further research and commercialization of its health-monitoring solutions.
Oct 2023Drug Delivery BusinessNews article
- MedCrypt Announces Series B Investment from Dexcom Venturessurgicalroboticstechnology.com/news/software/medcrypt-announces-additional-series-b-investment-from-dexcom-ventures/
MedCrypt secures additional Series B funding from Dexcom Ventures, the venture arm of Dexcom. The investment expands MedCrypt’s financial backing to support its growth in robotic surgery software solutions.
Jan 2023Surgical Robotics TechnologyNews article
- Lab-on-a-patch maker Nutromics scores $14M from Dexcom Ventures, othersmobihealthnews.com/news/anz/lab-patch-maker-nutromics-scores-14m-dexcom-ventures-others
Nutromics, a medtech startup developing lab-on-a-patch technology, secures a **$14 million funding round** led by **Dexcom Ventures**, alongside **VU Venture Partners** and **Artesian Investments**. The investment supports the company’s wearable diagnostic solutions, which integrate microfluidic and biosensor technologies for point-of-care testing. Nutromics targets applications in chronic disease monitoring and personalized healthcare.
Sep 2022MobiHealthNewsNews article